Type III Dysbetalipoproteinemia

Clinical trial NCT00214604 · COMPLETED

Trial details

NCT number: NCT00214604
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperlipoproteinemia Type III

Start date: 2005-02-01
Primary completion: 2007-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.